top of page
MyotonicPipeline.com
Astellas Gene Therapies
Drug: AT466
Approach: AAV-antisense
Status: Preclinical.
Company website explaining AT466.
April 8, 2019 Press Release announcing collaboration with Nationwide Children's Hospital
Dec. 2021 Press Release announcing collaboration with Dyno for viral vector delivery technology.
bottom of page